More Business Wire
View Older Stories View Newer Stories-
Pitney Bowes Declares Common Stock Dividend
-
Consensus Cloud Solutions to Participate at the Oppenheimer 26th Annual Technology, Internet & Communications Conference
-
Momentum Ventures Expresses Concerns About European Union's 2024 Travel Permit Requirement for Canadian and US Travelers
-
SimplePractice Announces Strategic Purchase of Assets of Luminello
-
Shift4 Announces Second Quarter 2023 Results
-
Superior Plus Declares Third Quarter Dividend
-
Superior Plus Announces Strong Second Quarter Results and Increases 2023 Adjusted EBITDA Guidance
-
CHIMERA INVESTMENT CORPORATION REPORTS 2ND QUARTER 2023 EARNINGS
-
Superior Reports Second Quarter 2023 Financial Results
-
The Middleby Corporation Reports Record Second Quarter Results
-
Gannett Announces Second Quarter 2023 Results and Raises Full Year Outlook
-
Workiva Inc. to Host 2023 Analyst & Investor Day on September 19th
-
ConocoPhillips Reports Second-Quarter 2023 Results; Raises Full-Year Production Guidance and Declares Quarterly Dividend and Variable Return of Cash Distribution
-
Shake Shack Announces Second Quarter 2023 Financial Results
-
Pitney Bowes Announces Second Quarter 2023 Financial Results
-
Laser Photonics Highlights the CleanTech's Ability to Remove Corrosion from Oil and Gas Pipes
-
Dine Brands Global, Inc. Reports Second Quarter 2023 Results
-
Bruker Reports Second Quarter 2023 Financial Results
-
Dream Finders Announces Second Quarter 2023 Results
-
Kinaxis Enhances Executive Leadership to Continue Company Growth
-
AlloVir Reports Second Quarter 2023 Financial Results
-
New Jersey Resources Reports Fiscal 2023 Third-Quarter Results
-
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
-
CareDx to Report Second Quarter 2023 Financial Results
-
Chimera Declares Third Quarter 2023 Common and Preferred Stock Dividends
-
Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Clinical Trial of CEL383, an Anti-TREM1 Antibody for the Treatment of Inflammatory Bowel Disease
-
Papa Johns Announces Second Quarter 2023 Financial Results; Increases Cash Dividend by 10%
-
First Foundation Inc. Appoints James Britton as Chief Financial Officer
-
Coya Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023
-
Nautilus Names Curt Chalmers Chief Underwriting Officer
-
Arbor Day Foundation Reports Nearly 25% Increase in Community Tree Plantings, Distributions Last Fiscal Year
-
EngageSmart Announces Second Quarter 2023 Results
-
Endor Labs Raises $70M to Reform Application Security and Eliminate Developer Productivity Tax
-
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Dollar General Corporation Announces Webcast of its Second Quarter 2023 Earnings Conference Call
-
Click Therapeutics Announces Participation in Upcoming Technology and Biotechnology Investor Events
-
Hyatt Reports Second Quarter 2023 Results
-
Kontoor Brands Reports 2023 Second Quarter Results; Reaffirms 2023 Outlook Excluding Restructuring Charges Associated With Strategic Actions
-
Solo Brands Reports Strong Second Quarter Results
-
The Buckle, Inc. Reports July 2023 Net Sales
-
Constellation Reports Second Quarter 2023 Results
-
APi Group Reports Record Second Quarter 2023 Financial Results
-
Iron Mountain Reports Second Quarter Results
-
Sally Beauty Holdings Reports Third Quarter Fiscal 2023 Results; Maintains Full Year Sales Guidance and Updates Operating Margin Outlook to High End of Previous Range
-
NuStar Energy L.P. Reports Solid Second Quarter 2023 Earnings Results
-
Canada Goose Reports First Quarter Fiscal 2024 Results
-
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
-
Tapestry, Inc. to Host FY23 Fourth Quarter and Year-End Earnings Call
-
Iron Mountain Increases Quarterly Dividend per Share by 5%
-
Advanced Drainage Systems Announces Quarterly Cash Dividend
